Trademark: 86871218
Status Date
Friday, December 22, 2023
Registration Number
5219373
Registration Date
Tuesday, June 6, 2017
Filing Date
Monday, January 11, 2016
Published for Opposition
Tuesday, January 3, 2017
Cancellation Date
Friday, December 22, 2023
5 Colchicine based pharmaceutical preparations for the prevention of gout flares, recurrent pericarditis, familial Mediterranean fever (FMF), Behcet's disease and long-term atrial fibrillation; Colchicine based pharmaceutical preparations for the treatment of acute gout flares, acute pericarditis, on-going Behcet's disease, familial Mediterranean fever (FMF), and acute atrial fibrillation attack
Dec 22, 2023
Cancelled Sec. 8 (6-Yr)
Jun 6, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 6, 2017
Registered-Principal Register
May 5, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
May 4, 2017
Allowed Principal Register - Sou Accepted
Mar 23, 2017
Statement Of Use Processing Complete
Mar 3, 2017
Use Amendment Filed
Mar 15, 2017
Case Assigned To Intent To Use Paralegal
Mar 3, 2017
Teas Statement Of Use Received
Feb 28, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 3, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2017
Published For Opposition
Dec 14, 2016
Notification Of Notice Of Publication E-Mailed
Nov 26, 2016
Approved For Pub - Principal Register
Nov 3, 2016
Teas/Email Correspondence Entered
Nov 3, 2016
Correspondence Received In Law Office
Nov 3, 2016
Teas Response To Office Action Received
May 5, 2016
Notification Of Priority Action E-Mailed
May 5, 2016
Priority Action E-Mailed
May 5, 2016
Priority Action Written
Apr 26, 2016
Assigned To Examiner
Jan 16, 2016
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
